Chlamydia and Gonorrhea Infections in Genital and Extragenital Samples among Men and Women
- PMID: 40772619
- DOI: 10.1097/OLQ.0000000000002154
Chlamydia and Gonorrhea Infections in Genital and Extragenital Samples among Men and Women
Abstract
Background: For people who have anal and/or oral sex, many programs recommend genital and extragenital (defined here as anorectal and oropharyngeal) screening for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) to identify all potential sites of infection.
Methods: We assessed genital and extragenital CT and NG prevalence among people reporting extragenital sexual exposure.
Results: Among 343 gay and bisexual men who reported sex with men (GBMSM), 42 (12.2%) had CT with positivity of 3.5%, 9.3% and 1.8% in the genital, anal, and oral samples, respectively. In this same group, 55 (16.0%) had NG with positivity of 5.2%, 8.5%, and 7.6% in the genital, anal, and oral samples, respectively. If only genital screening had been performed, 71.4% of CT infections and 67.3% of NG infections in GBMSM would have gone undetected. Among 96 men who only have sex with women (MSW), 10 (10.4%) had chlamydial infection-all detected in genital samples with no extragenital infections detected. Nine gonococcal infections (9.4%) were detected in MSW, with positivity of 6.3%, 2.1%, and 3.1% in the genital, anal, and oral samples, respectively. If only genital testing had been performed, no CT infections would have been missed among MSW; however, 33.3% of NG infections would have been missed. Among 329 cisgender women, 35 (10.6%) had CT with positivity of 7.9%, 6.1%, and 1.8% in the genital, anal, and oral samples, respectively. In the same group, 17 (5.2%) had NG with positivity of 4.0%, 2.1%, and 2.4% in the genital, anal, and oral samples, respectively. Among these women, 25.7% and 23.5% of CT and NG infections, respectively, would not have been detected.
Conclusions: The increased case finding when including extragenital testing for GBMSM and women was confirmed in this analysis. However, the benefit-cost ratio and the clinical or public health value of extragenital screening in these different populations requires further study.
Keywords: Extragenital; Genital; STI detection; STI screening.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Sexually Transmitted Diseases Association.
Similar articles
-
Prevalence of chlamydial, gonococcal and syphilis positivity by anatomical site and sex via self-collected biospecimens using at-home testing kits among a large and diverse cohort of men and women enrolled in the MACS/WIHS Combined Cohort Study (MWCCS) in the USA.Sex Transm Infect. 2025 Jul 25:sextrans-2025-056508. doi: 10.1136/sextrans-2025-056508. Online ahead of print. Sex Transm Infect. 2025. PMID: 40713184
-
Extragenital Sexually Transmitted Infection Testing Among Louisiana Parish Health Units, 2016-2019.Sex Transm Dis. 2023 May 1;50(5):274-279. doi: 10.1097/OLQ.0000000000001764. Epub 2023 Jan 8. Sex Transm Dis. 2023. PMID: 36630331 Free PMC article.
-
Extragenital Sexually Transmitted Infections Among High-Risk Men Who Have Sex With Men in Johannesburg, South Africa.Sex Transm Dis. 2024 Apr 1;51(4):245-250. doi: 10.1097/OLQ.0000000000001927. Epub 2024 Jan 10. Sex Transm Dis. 2024. PMID: 38534082
-
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. doi: 10.1002/14651858.CD001230.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646068
-
Interventions for treating genital Chlamydia trachomatis infection in pregnancy.Cochrane Database Syst Rev. 2017 Sep 22;9(9):CD010485. doi: 10.1002/14651858.CD010485.pub2. Cochrane Database Syst Rev. 2017. PMID: 28937705 Free PMC article.
LinkOut - more resources
Full Text Sources